Comparing diuretic strategies for outpatient worsening heart failure
Treatments studied
Part of Heart & circulation clinical trials.
This study tests different ways of giving diuretics (water pills) to people with worsening heart failure who are not in the hospital. The goal is to find a safer and more effective strategy to manage symptoms and reduce the need for hospitalization.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have been diagnosed with chronic heart failure.
- You are experiencing worsening heart failure symptoms that require IV diuretics in an outpatient clinic rather than in the hospital.
- You have signs of fluid build-up (congestion) that can be measured.
- You are already taking a diuretic (water pill) by mouth for heart failure.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new way to adjust diuretic (water pill) doses based on urine sodium levels in patients hospitalized for worsening heart failure. The goal is to improve fluid removal and get patients home sooner.
This study looks at how your kidneys handle salt and water when you're treated for acute heart failure in the hospital. Researchers want to understand which patients recover well from fluid buildup and which might need different treatment approaches.
This trial tests different water pill (diuretic) strategies for people hospitalized with acute heart failure and too much fluid. It is designed for patients who may not respond well to standard water pills, to find a more effective way to relieve symptoms.
This trial compares two different water pills (acetazolamide and metolazone) added to standard treatment to help remove excess fluid in people hospitalized with acute heart failure. The goal is to find which works better to ease symptoms and improve recovery.
This study tests whether adding acetazolamide or metolazone to standard treatment helps remove extra fluid better in people hospitalized for heart failure. It aims to find a safer and more effective option for managing fluid overload.
This trial tests whether adding an oral water pill (acetazolamide) to standard IV furosemide helps people with acute heart failure who have fluid overload. It aims to see if the combination improves outcomes better than furosemide alone.
Hear when a new Acute Heart Failure (AHF) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.